Bioventix PLC (LON:BVXP - Get Free Report)'s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 2,650 ($34.22) and last traded at GBX 2,698 ($34.84), with a volume of 24322 shares traded. The stock had previously closed at GBX 2,775 ($35.83).
Bioventix Trading Up 2.6 %
The stock has a market capitalization of £140.75 million, a price-to-earnings ratio of 17.38 and a beta of 0.35. The company's 50 day moving average is GBX 2,959.38 and its 200 day moving average is GBX 3,417.45.
About Bioventix
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Recommended Stories
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
